Demin O, Karelina T, Svetlichniy D, Metelkin E, Speshilov G, Demin O Jr, Fairman D, van der Graaf PH, Agoram BM. Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors. 2013 CPT Pharmacometrics Syst Pharmacol. 2, e74.
Benson N., Matsuura T., Smirnov S., Demin O., Jones HM., Dua P., van der Graaf PH. Systems pharmacology of the nerve growth factor pathway: use of a systems biology model for the identification of key drug targets using sensitivity analysis and the integration of physiology and pharmacology. 2013 Interface Focus 3: 20120071.
Demin OO, Smirnov SV, Sokolov VV, Cucurull-Sanchez L, Pichardo-Almarza C, Flores MV, Benson N, Demin OV. Modeling of celiac disease immune response and the therapeutic effect of potential drugs. 2013 BMC Syst Biol. 56.
Karelina TA, Zhudenkov KV, Demin OO, Svetlichny DV, Agoram B, Fairman D, Demin OV. Regulation of leukotriene and 5oxoETE synthesis and the effect of 5-lipoxygenase inhibitors: a mathematical modeling approach. BMC Syst Biol. 2012 Nov 12;6(1):141.
Peskov K, Mogilevskaya E, Demin O. Kinetic modelling of central carbon metabolism in Escherichia?coli. FEBS J. 2012 Sep;279(18):3374-85.
Benson N, Cucurull-Sanchez L, Demin O, Smirnov S, van der Graaf P. Reducing systems biology to practice in pharmaceutical company research; selected case studies. Adv Exp Med Biol. 2012;736:607-15.
Thank you for your message! We will get back to you shortly.
First
Prev